Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-24-042774

Options or other derivatives

  • Chief Financial Officer acquired 49,038 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BLOCH KATHLEEN P. Chief Financial Officer 2024-03-29 Grant or award · Stock Option (Right to Buy) +49,038 49,038 D
Loading xslF345X05/tm2410664-2_4seq1.xml…